BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32393278)

  • 1. Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases.
    Sadeghian Chaleshtori S; Mokhber Dezfouli MR; Jabbari Fakhr M
    Respir Res; 2020 May; 21(1):110. PubMed ID: 32393278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.
    Bari E; Ferrarotti I; Torre ML; Corsico AG; Perteghella S
    J Control Release; 2019 Sep; 309():11-24. PubMed ID: 31326462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell trials for pulmonary diseases.
    Antunes MA; Laffey JG; Pelosi P; Rocco PR
    J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells for therapeutic applications in pulmonary medicine.
    Stabler CT; Lecht S; Lazarovici P; Lelkes PI
    Br Med Bull; 2015 Sep; 115(1):45-56. PubMed ID: 26063231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells and inflammatory lung diseases.
    Iyer SS; Co C; Rojas M
    Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell therapy approaches for lung diseases: current status.
    Sueblinvong V; Weiss DJ
    Curr Opin Pharmacol; 2009 Jun; 9(3):268-73. PubMed ID: 19349209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.
    Inamdar AC; Inamdar AA
    Exp Lung Res; 2013 Oct; 39(8):315-27. PubMed ID: 23992090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.
    Leuning DG; Reinders ME; Li J; Peired AJ; Lievers E; de Boer HC; Fibbe WE; Romagnani P; van Kooten C; Little MH; Engelse MA; Rabelink TJ
    Stem Cells Transl Med; 2017 Feb; 6(2):405-418. PubMed ID: 28191776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.
    Srour N; Thébaud B
    Stem Cells Transl Med; 2015 Dec; 4(12):1500-10. PubMed ID: 26494779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis.
    Silva JD; Lopes-Pacheco M; de Castro LL; Kitoko JZ; Trivelin SA; Amorim NR; Capelozzi VL; Morales MM; Gutfilen B; de Souza SAL; Weiss DJ; Diaz BL; Rocco PRM
    Stem Cell Res Ther; 2019 Aug; 10(1):264. PubMed ID: 31443678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases.
    Ryu JS; Jeong EJ; Kim JY; Park SJ; Ju WS; Kim CH; Kim JS; Choo YK
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cell conditioned media for lung disease: a systematic review and meta-analysis of preclinical studies.
    Emukah C; Dittmar E; Naqvi R; Martinez J; Corral A; Moreira A; Moreira A
    Respir Res; 2019 Oct; 20(1):239. PubMed ID: 31666086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease.
    Mohammadipoor A; Antebi B; Batchinsky AI; Cancio LC
    Respir Res; 2018 Nov; 19(1):218. PubMed ID: 30413158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
    Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
    Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.
    Hu C; Wu Z; Li L
    J Cell Mol Med; 2020 Jan; 24(1):40-49. PubMed ID: 31691463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mesenchymal stromal cells in treatment of lung disorders.
    Kardia E; Zakaria N; Sarmiza Abdul Halim NS; Widera D; Yahaya BH
    Regen Med; 2017 Mar; 12(2):203-216. PubMed ID: 28244823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease.
    Worthington EN; Hagood JS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow mesenchymal stem cells and condition media diminish inflammatory adhesion molecules of pulmonary endothelial cells in an ovalbumin-induced asthmatic rat model.
    Rahbarghazi R; Keyhanmanesh R; Aslani MR; Hassanpour M; Ahmadi M
    Microvasc Res; 2019 Jan; 121():63-70. PubMed ID: 30343002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells overexpressing heme oxygenase-1 ameliorate lipopolysaccharide-induced acute lung injury in rats.
    Chen X; Wu S; Tang L; Ma L; Wang F; Feng H; Meng J; Han Z
    J Cell Physiol; 2019 May; 234(5):7301-7319. PubMed ID: 30362554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cells to Regenerate Emphysema: On the Horizon?
    Kruk DMLW; Heijink IH; Slebos DJ; Timens W; Ten Hacken NH
    Respiration; 2018; 96(2):148-158. PubMed ID: 29719298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.